X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hema13 (50) 50
humans (49) 49
oncology (49) 49
index medicus (48) 48
original reports (44) 44
adult (40) 40
middle aged (39) 39
female (38) 38
male (37) 37
aged (35) 35
treatment outcome (27) 27
aged, 80 and over (20) 20
young adult (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
adolescent (16) 16
disease-free survival (15) 15
drug administration schedule (13) 13
hema15 (13) 13
neoplasm staging (13) 13
rituximab (12) 12
antineoplastic agents - therapeutic use (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
disease (10) 10
hodgkin disease - drug therapy (10) 10
bone2 (9) 9
chemotherapy (9) 9
doxorubicin - administration & dosage (9) 9
kaplan-meier estimate (9) 9
non-hodgkins-lymphoma (9) 9
risk factors (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
cyclophosphamide - administration & dosage (8) 8
hema11 (8) 8
hema12 (8) 8
hema14 (8) 8
hema16 (8) 8
prednisone - administration & dosage (8) 8
recurrence (8) 8
vincristine - administration & dosage (8) 8
antineoplastic agents - administration & dosage (7) 7
etoposide - administration & dosage (7) 7
hema5 (7) 7
hodgkin disease - pathology (7) 7
lymphoma, large b-cell, diffuse - drug therapy (7) 7
transplantation, autologous (7) 7
antibodies, monoclonal, murine-derived - administration & dosage (6) 6
antineoplastic agents - adverse effects (6) 6
cancer (6) 6
prognosis (6) 6
remission induction (6) 6
survival (6) 6
trial (6) 6
united states (6) 6
child (5) 5
combined modality therapy (5) 5
cytarabine - administration & dosage (5) 5
doxorubicin - adverse effects (5) 5
hema10 (5) 5
hematopoietic stem cell transplantation (5) 5
lymphoma, non-hodgkin - drug therapy (5) 5
lymphoma, t-cell, peripheral - drug therapy (5) 5
risk (5) 5
therapy (5) 5
vinblastine - administration & dosage (5) 5
antibodies, monoclonal - therapeutic use (4) 4
antibodies, monoclonal, murine-derived (4) 4
bios3 (4) 4
bleomycin - administration & dosage (4) 4
dacarbazine - administration & dosage (4) 4
diagnosis in oncology (4) 4
drug resistance, neoplasm (4) 4
elderly-patients (4) 4
hema17 (4) 4
hodgkin disease - radiotherapy (4) 4
immunoconjugates - therapeutic use (4) 4
lymphoma, large b-cell, diffuse - immunology (4) 4
lymphoma, mantle-cell - drug therapy (4) 4
malignancies (4) 4
methotrexate (4) 4
prednisone - adverse effects (4) 4
prospective studies (4) 4
regimen (4) 4
retrospective studies (4) 4
risk assessment (4) 4
survival rate (4) 4
time factors (4) 4
vinblastine - adverse effects (4) 4
vincristine - adverse effects (4) 4
administration, oral (3) 3
antibodies, monoclonal - administration & dosage (3) 3
bleomycin - adverse effects (3) 3
carmustine - administration & dosage (3) 3
central nervous system neoplasms - drug therapy (3) 3
chronic lymphocytic-leukemia (3) 3
cyclophosphamide (3) 3
dacarbazine - adverse effects (3) 3
dxst3 (3) 3
expression (3) 3
fatigue - chemically induced (3) 3
follicular lymphoma (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2670 - 2677
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2013, Volume 31, Issue 33, pp. 4199 - 4206
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2015, Volume 33, Issue 23, pp. 2492 - 2499
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2014, Volume 32, Issue 2, pp. 114 - 120
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2016, Volume 34, Issue 17, pp. 2020 - 2027
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 32, pp. 5410 - 5417
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2015, Volume 33, Issue 32, pp. 3759 - 3765
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2015, Volume 33, Issue 32, pp. 3750 - 3758
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4184 - 4190
Purpose Salvage chemotherapy followed by high-dose therapy and autologous stem-cell transplantation (ASCT) is the standard treatment for relapsed diffuse large... 
SURVIVAL | PARMA TRIAL | THERAPY | BONE-MARROW TRANSPLANTATION | ONCOLOGY | NON-HODGKINS-LYMPHOMA | CHOP | AGGRESSIVE LYMPHOMA | RANDOMIZED CONTROLLED-TRIAL | CHEMOTHERAPY PLUS RITUXIMAB | ELDERLY-PATIENTS | Recurrence | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | New York City | Stem Cell Transplantation | Young Adult | Time Factors | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Antigens, CD20 - analysis | Chemotherapy, Adjuvant | Antibodies, Monoclonal, Murine-Derived | Dexamethasone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - surgery | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Rituximab | Etoposide - administration & dosage | Treatment Outcome | Cytarabine - administration & dosage | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Ifosfamide - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Israel | Australia | Neoplasm Staging | Bone2 | Original Reports | Hema13 | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | Surgery | Onkologi | Oncology | Cancer and Oncology | Klinisk medicin | MEDICINE | Kirurgi | Cancer och onkologi
Journal Article